Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a recent site update that does not alter the study details presented.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing v3.6.0. This represents a software version update for the page's interface without changing trial details.SummaryDifference0.0%

- Check31 days agoChange DetectedThe study record now indicates that recruitment has ended and the sponsor terminated the study, with no participants being sought going forward.SummaryDifference0.4%

- Check39 days agoChange DetectedThe page shows a revision tag updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a site update or deployment. This change does not modify any study content or visible information on the page.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision identifier was updated from v3.5.3 to v3.5.4, indicating a minor update to the published version. This change does not modify visible content or functionality on the page.SummaryDifference0.0%

- Check74 days agoChange Detected- The page revision was updated from v3.5.2 to v3.5.3, indicating a new site release. This update is metadata-only and does not modify study content or displayed information.SummaryDifference0.1%

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.